Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: WeirdPro Randy who wrote (1048)	2/18/1998 10:09:00 AM
From: mattie	Read Replies (1) \| Respond to of 1359

WPR, All I know is that there are some very sophisticated investors, with great track records that are very short this stock. One or more 'short only' research firms - that cater to the hedge fund community (to help generate ideas) has a strong sell on the stock. These analysts are very knowledgeable from both the scientific and the financial 'street smart' end. From what I know they are basing this recommendation on the fact that Redux had approx. 6 million prescriptions written. They are estimating that as many as 1/3 of the users may have some sort of heart valve problem. Therefore there could be 2 million lawsuits against AHP and IPIC. That is more liability than IPIC could handle and they would be forced into bankruptcy. I hope this helps. Good Luck!